Athira Pharma's total assets for Q3 2025 were $30.03M, a decrease of -15.51% from the previous quarter. ATHA total liabilities were $3.25M for the fiscal quarter, a -8.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.